Примери за използване на Boosted darunavir на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Boosted darunavir may increase the exposure to grazoprevir.
The combination of rifapentine and boosted darunavir is not recommended.
Boosted darunavir and didanosine can be used without dose adjustments.
Concomitant use of salmeterol and boosted darunavir is not recommended.
Boosted darunavir can be used with these NRTIs without dose adjustment.
It is not recommended to coadminister boosted darunavir and boceprevir.
The use of boosted darunavir and these anticoagulants is not recommended.
It is not recommended to co-administer boosted darunavir and boceprevir.
Boosted darunavir and rilpivirine can be used without dose adjustments.
It is not recommended to coadminister boosted darunavir and simeprevir.
Boosted darunavir and dolutegravir can be used without dose adjustment.
Concomitant use of salmeterol and boosted darunavir is not recommended.
Boosted darunavir is expected to increase these antipsychotic plasma concentrations.
Co-administration of domperidone with boosted darunavir is contraindicated.
Boosted darunavir is expected to increase these antipsychotic plasma concentrations.
Concominant use of everolimus or irinotecan and boosted darunavir is not recommended.
Boosted darunavir is expected to increase these antineoplastic plasma concentrations.
It is not recommended to co-administer boosted darunavir with glecaprevir/pibrentasvir.
Boosted darunavir is expected to increase these antiarrhythmic plasma concentrations.
The combination of rifampicin and boosted darunavir is contraindicated(see section 4.3).
Warfarin concentrations may be affected when coadministered with boosted darunavir.
Co-administration of boosted darunavir and naloxegol is contraindicated.
Warfarin concentrations may be affected when co-administered with boosted darunavir.
Co-administration of boosted darunavir with dapoxetine is contraindicated.
Systemic dexamethasone should be used with caution when combined with boosted darunavir.
Boosted darunavir can be coadministered with H2-receptor antagonists without dose adjustments.
Systemic dexamethasone should be used with caution when combined with boosted darunavir.
Boosted darunavir can be expected to increase the plasma concentrations of calcium channel blockers.
Concomitant use of bosentan and boosted darunavir may increase plasma concentrations of bosentan.
Concomitant use of boosted darunavir and these antidepressants may increase concentrations of the antidepressant.